CXCL8 and gastric cancer: Moreover, a study in human gastric cancer identified a CD45+CD33lowCD11bdim MDSC subset capable of suppressing CD8+ T cell function via the IL-6/IL-8–arginase I axis, which also expressed CD66b.46